| 名称 | Iladatuzumab |
| 描述 | Iladatuzumab (MCDS0593A) is a monoclonal antibody targeting CD79B and is a naked antibody to the ADC compound Iladatuzumab vedotin, which has potential anticancer activity for the study of B-cell non-Hodgkin's lymphoma (B-NHL). |
| 存储条件 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 关键字 | ADCAntibody | ADC Antibody |
| 相关产品 | Teneligliptin hydrobromide | Trastuzumab | (9α,13α,14α)-4-Hydroxy-3,7-dimethoxy-7,8-didehydromorphinan-6-one | MG-T-19 | Anti-inflammatory agent 35 | Sacituzumab | beta-Escin | Brentuximab | Pirazolac | Reltecimod TFA | Anti-inflammatory agent 36 | Benzyl cinnamate |
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断、治疗或实验，不可药用，不可食用。
Copyright© 2022-2026 上海捷世凯生物科技有限公司 版权所有，All Rights Reserved 沪ICP备2022023965号
沪公网安备 31012002005937 
许可证编号：沪（奉）应急管危经许[2025]203724
主管 朱如燕 13795461237
售后 全香 15901740225
微信公众号
